T4 preinfected mice were treated with anti-IL-17A antibodies or the isotype control antibody on days −1, 0, and 1 by intraperitoneal injection and intranasally on day 0 during T4 challenge following PR8 infection (Fig. 5A). This evidence concerns the gene IL17A and infection.